Pharmakon Advisors

Private Equity SEC-registered adviser

Legal name: Pharmakon Advisors, LP

New York, NY Website

AUM

$3.0B
Regulatory AUM

Private funds

1
Private Equity 1

Private fund assets

$1.9B
Gross asset value

Employees

15

Last Form D raise

May 2026
Most recent fund filing

From SEC Form ADV filing (filed Mar 31, 2026). View on SEC

People(2)

Owners and executive officers named on the firm's SEC Form ADV.

P
Pablo Legorreta
Managing Member, Pharmakon Management I
Source: SEC Form ADV
P
Pedro Gonzalez de Cosio
Chief Executive Officer, Limited Partner
Source: SEC Form ADV

Funds(1)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Biopharma Credit Investments V (master) LPPrivate Equity$1.9B$12.5M1May 2026Hot

Board seats

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

No board seats matched from SEC filings yet.

Regulatory identifiers

CRD number
161150
SEC file number
801-74263

Sources